Quantessence Capital’s Amdocs DOX Stock Holding History

Quantessence Capital’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,100	Closed	-$833K	–	258
2025 Q1	$833K	Buy	+9,100	New	+$794K	0.21%	144

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Quantessence Capital's DOX Position: Q2 2025 in Review

Quantessence Capital sold out of Amdocs (DOX) in Q2 2025, closing a stake of 9,100 shares — an estimated $833K sold.

Quantessence Capital first reported a position in DOX in Q1 2025 and held it in 1 quarter. The position peaked at $833K in Q1 2025. 542 funds tracked by Wall St. Rank hold DOX as of Q2 2025.

Quantessence Capital reported no remaining Amdocs position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 9,100 Amdocs shares in Q2 2025, an estimated $833K.
Quantessence Capital first reported a position in Amdocs in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Amdocs position peaked at $833K in Q1 2025.
542 funds tracked by Wall St. Rank held Amdocs as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.